Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity
NCT ID: NCT06995742
Last Updated: 2025-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
270 participants
INTERVENTIONAL
2025-06-02
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vital Sensor Monitors for CV19 Detection
NCT04635787
Feasibility and Accuracy of a Wireless Vital Sign Monitor for Observation of Adult Patients in Uganda
NCT04761432
Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19
NCT04548895
Wireless Monitoring for Clinical Deterioration
NCT06644599
Validation of Fitbit Measurements in Hospitalized General Medicine Patients
NCT07229833
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention--Device Array Use
Inpatients will wear the ANNE One device array for obtainment of vital sign assessments.
Device Array Use
Study participants assigned to the intervention study arm will wear a wireless Bluetooth capable vital sign detection array, with one device externally worn on each of their chest, one finger, and one arm, with healthcare providers using an additional oral temperature probe.
Control--Routine Vital Sign Obtainment
Inpatients will have vital signs determined by routine practice, using any other standard of care-accepted method or device.
Routine Vital Sign Measurement
Study participants randomized to the control arm will have their vital signs obtained by routine means, without use of the wireless vital sign device array.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Device Array Use
Study participants assigned to the intervention study arm will wear a wireless Bluetooth capable vital sign detection array, with one device externally worn on each of their chest, one finger, and one arm, with healthcare providers using an additional oral temperature probe.
Routine Vital Sign Measurement
Study participants randomized to the control arm will have their vital signs obtained by routine means, without use of the wireless vital sign device array.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota Medical School/University of Minnesota Foundation
UNKNOWN
Sibel Health Inc.
INDUSTRY
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gregory Randall Smith Jr
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory (Randy) R Smith Jr, MD MS
Role: PRINCIPAL_INVESTIGATOR
Northwestern University Feinberg School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Feinberg 16 West, Northwestern Memorial Hospital
Chicago, Illinois, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023 Dixon Translational Grant
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
STU00219340
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.